Kisspeptin: Research Applications
$34.65 · COA do lote publicado · Água BAC grátis + frete grátis nos EUA · Despacho no mesmo dia antes das 14h ET · APENAS PARA USO EM PESQUISA
Comprar peptídeo Kisspeptin 10mg30 Citacoes PubMedRevisado por EspecialistasUltima Revisao: fevereiro de 2026
Aplicacoes de Pesquisa
Kisspeptin is one do(a) a maioria extensively studied reproductive neuropeptides, with >1,000 human subjects across Phase 1/2 ensaios clinicos:
- IVF Oocyte Maturation Trigger — Kp-54 has been studied as an oocyte-maturation trigger in IVF cohorts; oocyte-maturation, live-birth and OHSS endpoints are reported in the cited references.[10][11]
- Hypothalamic Amenorrhea — LH-pulsatility endpoints reported over an 8-week study.[12][13][19]
- PCOS — LH and estradiol endpoints were reported with KP-10 in women with polycystic ovary syndrome.[15]
- Metabolic / Fatty Liver Disease — TAK-448 reduz hepatico(a) triglycerides, serum FFA, and ALT in MASLD models via AMPK→SREBP-1c→CIDEA downregulacao.[18]
- Cancer Metastasis Suppression — Originally identificado(a) como melanoma/breast cancer metastasis suppressor ("metastin"); inibe MMP-9 via NF-κB pathway supressao.[1]
- Prostate Cancer (Androgen Deprivation) — Continuous TAK-448/MVT-602 exposure → receptor dessensibilizacao → testosterone supressao to castrate levels (Phase 1 data).[14]
- Pregnancy Biomarker — Kisspeptin rises 7,000-fold during healthy pregnancy; baixo(a) levels predict miscarriage/preeclampsia by assessing trophoblast invasion.[20]
- Bone Health — Promotes osteoblasto diferenciacao, inibe osteoclasto activity; osteocalcin endpoints have been reported in men.[21]
- Puberty Disorders — Activating/inactivating KISS1/KISS1R mutations linked to precocious/retardou puberty; kisspeptin challenge tests used diagnostically.[4]
- Metabolic Insulin Signaling — glucose-stimulated insulin-secretion endpoints have been reported in healthy men.[22]
Editorial Research Note
“Resumo da Pesquisa Pre-clinica Key Preclinical Studies EstudoModeloPrincipais AchadosRef Mills et al.”
Referencias
- Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. Journal do(a) National Cancer Institute. 1996;88(23):1731-1737.
- Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411(6837):613-617.
- Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands do(a) orphan G protein-coupled receptor GPR54. Journal of Biological Chemistry. 2001;276(37):34631-34636.
- Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene como um(a) regulator of puberty. New England Journal of Medicine. 2003;349(17):1614-1627.
- Dhillo WS, Chaudhri OB, Patterson M, et al. Journal of Clinical Endocrinology & Metabolism. 2005;90(12):6609-6615.
- Dhillo WS, Chaudhri OB, Thompson EL, et al. Journal of Clinical Endocrinology & Metabolism. 2007;92(10):3958-3966.
- World Anti-Doping Agency. The Lista de Substancias Proibidas. S2 Hormonios Peptidicos, Fatores de Crescimento, Substancias Relacionadas e Mimeticos. WADA. Updated 2025.
- de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Proceedings do(a) National Academy of Sciences. 2003;100(19):10972-10976.
- Abbara A, Eng PC, Phylactou M, et al. Journal of Clinical Investigation. 2020;130(12):6739-6753.
- Abbara A, Jayasena CN, Christopoulos G, et al. Journal of Clinical Endocrinology & Metabolism. 2015;100(9):3322-3331.
- Abbara A, Clarke S, Islam R, et al. Human Reproduction. 2017;32(9):1915-1924.
- Jayasena CN, Nijher GM, Chaudhri OB, et al. Journal of Clinical Endocrinology & Metabolism. 2009;94(11):4315-4323.
- Jayasena CN, Nijher GM, Abbara A, et al. Clinical Pharmacology & Therapeutics. 2010;88(6):840-847.
- MacLean DB, Matsui H, Suri A, Neuwirth R, Colombel M. Journal of Clinical Endocrinology & Metabolism. 2014;99(8):E1445-E1453.
- Skorupskaite K, et al. Human Reproduction. 2020.
- Comninos AN, Wall MB, Demetriou L, et al. Journal of Clinical Investigation. 2017;127(2):709-719.
- Mills EG, et al. JAMA Network Open. 2023.
- Izarraras L, et al. Kisspeptin agonist reduz hepatico(a) de novo lipogenesis in MASLD via AMPK-SREBP-1c-CIDEA. 2025.
- Mills EG, et al. eBioMedicine. 2025.
- Jayasena CN, Abbara A, et al. Journal of Clinical Investigation. 2014;124(8):3667-3677.
- Comninos AN, et al. Journal of Clinical Endocrinology & Metabolism. 2022.
- Izzi-Engbeaya C, et al. Diabetes, Obesity and Metabolism. 2018.
- Seminara SB, et al. 2006.
- Terse PS, et al. 2021.
- Thompson EL, et al. 2006.
- Dinh TO, et al. Kisspeptin-13 exacerbates cronico(a) doenca renal and uremic cardiomiopatia in rats. 2023.
- George JT, Veldhuis JD, Roseweir AK, et al. Journal of Clinical Endocrinology & Metabolism. 2011;96(8):E1228-E1236.
- Thurston L, et al. JAMA Network Open. 2022.
- Nishizawa N, Takatsu Y, et al. Design and synthesis of TAK-448, an investigacional nonapeptide KISS1R agonist. Journal of Medicinal Chemistry. 2016;59(19):8804-8811.
- Chan YM, Butler JP, Pinnell NE, et al. Journal of Clinical Endocrinology & Metabolism. 2011;96(6):E908-E915.
Perguntas de Pesquisa Relacionadas
Related research
Browse all research guides in the Peptide Research Library →Deseja a revisao completa da pesquisa?
Comprar peptídeo Kisspeptin 10mg→APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.
